Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal differences affect male pattern baldness.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

Using Platelet-Rich Plasma injections for male-pattern baldness didn't significantly improve hair growth.

Serum IMA levels don't help diagnose AGA but may indicate its severity.

The comment questions the study's methods for diagnosing hair loss, the type of injections used, the reliability of hair count as a measure, the lack of detail about the procedure, and disagrees with the conclusion about the effect of needling.

Combining stem cell-conditioned media with anti-androgen drugs can improve hair growth in male pattern baldness.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

Vertex pattern hair loss linked to higher prostate cancer risk.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Androgenetic alopecia is significantly linked to metabolic syndrome.

Early onset hair loss in young men is common and linked to family history and alcohol use.

Hair loss link to COVID-19 severity likely due to other factors.

Men with androgenic alopecia have different hair copper levels than those without.

Hair loss in androgenic alopecia may be linked to increased local androgen activities, but not to estrogen levels.

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Certain metabolites can either protect against or increase the risk of hair loss.

Smoking increases the risk of male pattern hair loss.

Hormonal imbalances are important in the development of male pattern baldness.

Hair loss (androgenetic alopecia) mildly to moderately affects men's quality of life but not significantly their mental health.

Hair loss in men aged 25-44 may be linked to gum disease.

Androgenetic alopecia is more common in Saudi men than women.

Men with early-onset baldness may have a higher risk of heart disease.

Male pattern baldness involves three mechanisms and finasteride can help reverse it.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.

Unhealthy lifestyle and diet may increase the risk of early hair loss in young men.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.